SUPPLEMENTARY MATERIALS: A preclinical trial evaluating the efficacy of a topical formulation containing adipose-derived stem cell exosomes for the treatment of dupilumab-related facial redness in patients with atopic dermatitis

Published: 16 December 2022| Version 1 | DOI: 10.17632/jky8gfjx84.1
Contributor:
Young Gue Koh

Description

Supplemenatry materials for 'A preclinical trial evaluating the efficacy of a topical formulation containing adipose-derived stem cell exosomes for the treatment of dupilumab-related facial redness in patients with atopic dermatitis'

Files

Categories

Exosome

Licence